Publication & Citation Trends
Most Cited Works
Publications
71 total
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin PDF
Cited by 148
OpenAlex
The Cost-effectiveness of Therapy With Teriparatide and Alendronate in Women With Severe Osteoporosis PDF
Cited by 84
OpenAlex
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
Cited by 757
OpenAlex
CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.
Cited by 165
OpenAlex
Early Changes in Biochemical Markers of Bone Turnover Predict the Long-Term Response to Alendronate Therapy in Representative Elderly Women: A Randomized Clinical Trial
Cited by 239
OpenAlex
Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
Cited by 93
OpenAlex
Research Topics
Bone health and treatments
(15)
Bone health and osteoporosis research
(13)
Thyroid and Parathyroid Surgery
(13)
Growth Hormone and Insulin-like Growth Factors
(11)
Bone and Joint Diseases
(8)
Frequent Co-Authors
Affiliations
Roche (Switzerland)
Cedars-Sinai Medical Center
Merck & Co., Inc., Rahway, NJ, USA (United States)
San Francisco VA Medical Center
Center for Global Development